Non-Invasive Cancer Testing

The IvyGene test is a blood test that uses advanced DNA sequencing methods to detect the DNA methylation pattern of circulating tumor DNA (ctDNA) in blood samples in order to both confirm the presence of cancer and give quantitative data.

The IvyGene Score reflects the relative amount of cell-free DNA that contains these methylation markers as a percentage of the total cell-free DNA present. The IvyGenescore is derived from a composite average of methylated vs unmethylated cell-free DNA of specific target sites.

The IvyGene™ test has been validated with four (4) cancer tissues of origin: breast, colon, liver and lung cancers. The presence of other cancer types may also result in an elevated IvyGene™ Score.

Learn More



Firefighters interviewed about cancer and the IvyGene test. 
Bedford, Texas (Dallas/Ft. Worth Metroplex)
Watch the video above to learn about the incidence of cancer among Firefighters and how the City of Bedford is committed to making a difference.
The building blocks of IvyGene were published in Nature Materials.
Learn more about DNA Methylation and how this technology is being used in revolutionary new ways. Visit the link to learn more:
Dhruvajyoti Roy, PhD, director of technology for LAM , owners of the IvyGene technology, agrees that the combination vaccine has potential for clinical

Stop by and visit our booth at our upcoming conferences.

  • Society of Integrative Oncology (SIO)
    October 27-29, 2018 – Scottsdale, AZ
  • Age Management Medicine Group (AMMG)
    November 11-4, 2018 – Tucson, AZ

Learn More

Connect with Us